SCHEMBL24048276

SCHEMBL24048276

Clc1c(Br)ccc2c1sc1ccc3ccccc3c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.38
▸ HPRT1 P00492 1/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ CYP1A1 P04798 4/20 0.34
▸ CYP1B1 Q16678 4/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ NQO1 P15559 1/20 0.34
▸ NQO2 P16083 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24048317 0.82 CYP1B1 (0.42) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL13789873 0.81 HPRT1 (0.48) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL31192044 0.80 ALDH1A1 (0.38) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL17382916 0.80 ALDH1A1 (0.38) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL24048270 0.80 CYP2A6 (0.41) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL29364375 0.79 HPRT1 (0.46) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL2150778 0.79 HPRT1 (0.46) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL30612521 0.79 HPRT1 (0.46) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL17037122 0.79 HPRT1 (0.50) CYP2A6HPRT1L3MBTL1TSHRHSD17B10
SCHEMBL23981335 0.77 CYP1A2 (0.50) CYP2A6HPRT1L3MBTL1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
WO-2021235830-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, AHR, CRY2 CYP2A6 221/4885HPRT1 1617/4885L3MBTL1 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback